Cargando…
Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study
Acrylamide, which is present in many daily foods, is a probable human carcinogen. In 2002, it was identified in several common foods. Subsequently, western epidemiologists began to explore the relationship between dietary acrylamide exposure and cancer risk; however, limited suggestive associations...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916863/ https://www.ncbi.nlm.nih.gov/pubmed/33670108 http://dx.doi.org/10.3390/nu13020590 |
_version_ | 1783657574536577024 |
---|---|
author | Zha, Ling Liu, Rong Sobue, Tomotaka Kitamura, Tetsuhisa Ishihara, Junko Kotemori, Ayaka Ikeda, Sayaka Sawada, Norie Iwasaki, Motoki Tsugane, Shoichiro |
author_facet | Zha, Ling Liu, Rong Sobue, Tomotaka Kitamura, Tetsuhisa Ishihara, Junko Kotemori, Ayaka Ikeda, Sayaka Sawada, Norie Iwasaki, Motoki Tsugane, Shoichiro |
author_sort | Zha, Ling |
collection | PubMed |
description | Acrylamide, which is present in many daily foods, is a probable human carcinogen. In 2002, it was identified in several common foods. Subsequently, western epidemiologists began to explore the relationship between dietary acrylamide exposure and cancer risk; however, limited suggestive associations were found. This prospective study aimed to examine the association between dietary acrylamide intake and the risk of hematological malignancies, including malignant lymphoma (ML), multiple myeloma (MM), and leukemia. We enrolled 85,303 participants in the Japan Public Health Center-based Prospective study on diet and cancer as from 1995. A food frequency questionnaire that included data on acrylamide in all Japanese foods was used to assess dietary acrylamide intake. We applied multivariable adjusted Cox proportional hazards models to reckon hazard ratios (HRs) for acrylamide intake for both categorical variables (tertiles) and continuous variables. After 16.0 median years of follow-up, 326 confirmed cases of ML, 126 cases of MM, and 224 cases of leukemia were available for final multivariable-adjusted analysis. HRs were 0.87 (95% confidence interval [CI]: 0.64–1.18) for ML, 0.64 (95% CI: 0.38–1.05) for MM, and 1.01 (95% CI: 0.71–1.45) for leukemia. Our results implied that acrylamide may not be related to the risk of hematological malignancies. |
format | Online Article Text |
id | pubmed-7916863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79168632021-03-01 Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study Zha, Ling Liu, Rong Sobue, Tomotaka Kitamura, Tetsuhisa Ishihara, Junko Kotemori, Ayaka Ikeda, Sayaka Sawada, Norie Iwasaki, Motoki Tsugane, Shoichiro Nutrients Article Acrylamide, which is present in many daily foods, is a probable human carcinogen. In 2002, it was identified in several common foods. Subsequently, western epidemiologists began to explore the relationship between dietary acrylamide exposure and cancer risk; however, limited suggestive associations were found. This prospective study aimed to examine the association between dietary acrylamide intake and the risk of hematological malignancies, including malignant lymphoma (ML), multiple myeloma (MM), and leukemia. We enrolled 85,303 participants in the Japan Public Health Center-based Prospective study on diet and cancer as from 1995. A food frequency questionnaire that included data on acrylamide in all Japanese foods was used to assess dietary acrylamide intake. We applied multivariable adjusted Cox proportional hazards models to reckon hazard ratios (HRs) for acrylamide intake for both categorical variables (tertiles) and continuous variables. After 16.0 median years of follow-up, 326 confirmed cases of ML, 126 cases of MM, and 224 cases of leukemia were available for final multivariable-adjusted analysis. HRs were 0.87 (95% confidence interval [CI]: 0.64–1.18) for ML, 0.64 (95% CI: 0.38–1.05) for MM, and 1.01 (95% CI: 0.71–1.45) for leukemia. Our results implied that acrylamide may not be related to the risk of hematological malignancies. MDPI 2021-02-11 /pmc/articles/PMC7916863/ /pubmed/33670108 http://dx.doi.org/10.3390/nu13020590 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zha, Ling Liu, Rong Sobue, Tomotaka Kitamura, Tetsuhisa Ishihara, Junko Kotemori, Ayaka Ikeda, Sayaka Sawada, Norie Iwasaki, Motoki Tsugane, Shoichiro Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study |
title | Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study |
title_full | Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study |
title_fullStr | Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study |
title_full_unstemmed | Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study |
title_short | Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study |
title_sort | dietary acrylamide intake and the risk of hematological malignancies: the japan public health center-based prospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916863/ https://www.ncbi.nlm.nih.gov/pubmed/33670108 http://dx.doi.org/10.3390/nu13020590 |
work_keys_str_mv | AT zhaling dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT liurong dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT sobuetomotaka dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT kitamuratetsuhisa dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT ishiharajunko dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT kotemoriayaka dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT ikedasayaka dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT sawadanorie dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT iwasakimotoki dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT tsuganeshoichiro dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy AT dietaryacrylamideintakeandtheriskofhematologicalmalignanciesthejapanpublichealthcenterbasedprospectivestudy |